Spots Global Cancer Trial Database for The Registry of Genetic Expression of Taiwan Urologic Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Registry of Genetic Expression of Taiwan Urologic Cancer

Official Title: National Health Research Institutes,Taiwan

Study ID: NCT05725304

Conditions

Urologic Cancer

Interventions

Study Description

Brief Summary: This project is a nationwide precision medicine program for urothelial carcinoma and renal cell carcinoma.

Detailed Description: This project providing free and immediate next-generation gene sequencing testing for patients with urothelial and renal cell carcinomas that have is diagnosed or that have previously received systemic therapy. The goal of this project is to assist participating institutions in integrating next-generation sequencing results and building a real-time data storage and sharing platform, as well as establishing a tumor molecular biological atlas of Taiwanese patients with urothelial carcinoma and renal cell carcinoma. The data will be linked with clinical prognosis to facilitate the rapid screening of patients for effective potential therapeutic drugs and clinical trials, which is anticipated to prolong the survival rate of patients.